Navigation Links
China's Leading Healthcare Market Player Records 200% Increase in Profits and Earnings
Date:6/24/2008

HONG KONG, June 25 /Xinhua-PRNewswire-FirstCall/ -- Golden Meditech Company Limited ("Golden Meditech" or the "Group"; Stock Code: 8180.HK) today is pleased to announce its annual results for the financial year ended 31 March 2008. Driven by remarkable organic growth of core businesses and exceptional gains from strategic investments, the Group reported record profit (after-tax) of HK$713,653,000, a jump of 209% over last year. The Group's basic earnings per share increased by 198% to HK44.1 cents.

Turnover of the core businesses rose to HK$421,147,000, representing a rise of 27%. The realized gains from the strategic investments contributed HK$332,435,000 to the Group's profit, up 355% over last year. The Group's net asset value rose to HK$3,553,964,000 at a compound annual growth rate (CAGR) exceeding 47% over the last five years.

Mr. Kam Yuen, Chairman of Golden Meditech said, "We position ourselves as a high-growth, integrated hi-tech medical device and healthcare services enterprise. Golden Meditech is not only the largest blood related medical device manufacturer in China, but also the first and largest umbilical cord blood bank service provider in China. Golden Meditech has also had significant interest in one of the largest natural herbal healthcare chains in England and Ireland -- China Healthcare Inc. (CHI). We intend to maintain a leading dominant position in each of individual business segments."

Among the Group's three core business segments, the Medical Device Segment remained the principle source of the revenue, accounting for 67% of total revenue last year. However, the revenue contribution from the Cord Blood Bank Segment has been steadily rising after consecutive years of high growth, and its share has now rose from last year's 19% to 33% this year. The Medical Device Segment is expected to bring in stable and substantial revenue to the Group whereas the revenue of the Cord Blood Bank Segment will be rapidly increasing.
'/>"/>

SOURCE Golden Meditech Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
4. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
5. Leading-edge body sensor could help produce sporting champions
6. Hospital Quality Info on Web Can Be Misleading
7. AT&T Establishes New Network Services for Leading Medical Liability Insurer
8. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
9. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
10. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
11. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , NEWPORT BEACH, Calif., Dec. 1 /PRNewswire/ -... that insurers will reimburse them for the $20 cos...for ,going under, for surgery. ,, Anesthesiolog...onitoring is to avoid postop dementia from routine...ts have not heard the ,avoid over-medication, mess...
(Date:12/1/2009)... , SEATTLE, Dec. 1 /PRNewswire-FirstCall/ ...CTIC) management,s presentation at the 21st Annual...December 1 at 11:00 a.m. Eastern Time will be webc...e presentation will take place in Holmes 1 at the ...for replay after the presentation. , , ...
(Date:12/1/2009)...O A study presented today at the annual meeting o... revealed that MRI is a highly accurate means of i...reatening and increasingly common condition that i... and after giving birth. , "Due to the increase...ve scarring on the uterine wall, coupled with wome...
(Date:12/1/2009)...O Results of a randomized, controlled clinical tr...adiological Society of North America (RSNA) reveal...age in arteries that supply blood to the legs and ...silent coronary artery disease. , Peripheral ar...tion of fat, cholesterol and other substances, bui...
(Date:12/1/2009)...rst ever published study of aviation-related injur...013 patients are admitted to U.S. hospitals with a...iation-deaths occur each year. The study, conducte...School of Public Health,s Center for Injury Resear...s that the largest categories of patients were occ...
Breaking Medicine News(10 mins):Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2Health News:MRI helps detect life-threatening pregnancy complication 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2Health News:More than 1,000 patients in US admitted annually for aviation-related injuries 2
...ck Exchange Symbol: CYT, MONTREAL, July 30 /PRNew...a conference call to discuss its third quarter 200... Tuesday, August 5, 2008. The call will be,hosted ... Tuesday, August 5., DATE: Tuesd...
...e highlights that will be presented during the edu...r medical oncology meeting include:, Molecular a...chilles, heel, MicroRNa, SiRNA libraries, Protein...New targets for triple negative tumors, Stem cell ...
... to overwhelming industry interest in new products... Exhibition, VendorClear™ announces that Ven... available for purchase on limited release. , ...[vendor access services] for healthcare facilities...
...ed that it has,signed a new deal with Harro Hoflig...t for the pharmaceutical industry. Harro Hofliger ...stomers minimize risk and,manage quality effective...companies. Among its 400-strong customer base are ...
...ervices,Inc. (NYSE: ACS ) today announced a $4 mi...ds capture for the City of New Orleans Emergency,M... the five-year contract, ACS will equip all New,Or...-time, whether in the field at a patient,s side or...
...oss-border prevention, treatment programs , ...s of HIV infection increase fourfold for male inje... the United States compared to non-deportees in th...est further investigation is necessary into the ri...
Other Medicine News:Health News:CryoCath to Hold Third Quarter 2008 Conference Call and Webcast 2Health News:Get the latest on premier science in medical oncology 2Health News:Get the latest on premier science in medical oncology 3Health News:Get the latest on premier science in medical oncology 4Health News:VendorClear™ Announces Limited Release of New Products for Healthcare Facilities and Vendor Representatives 2Health News:Harro Hofliger Reduces Risk in Pharmaceutical Manufacturing Equipment with Dyadem 2Health News:Harro Hofliger Reduces Risk in Pharmaceutical Manufacturing Equipment with Dyadem 3Health News:ACS Awarded $4 Million Contract to Provide Electronic Patient Records for City of New Orleans EMS 2Health News:Deportation Tied to Higher HIV Risk for Men Injecting Drugs 2Health News:Deportation Tied to Higher HIV Risk for Men Injecting Drugs 3
(Date:11/30/2009)... , HUNTERSVILLE, N.C., Nov. 30 ... built-in antimicrobial product protection, is ple...tnership with Dal-Tile Corp., the largest U.S. man...ral stone. Dal-Tile Corp is launching two new lin...aturing Microban(®) patent pending silver bas...
(Date:11/30/2009)... , PRINCETON, N.J., Nov. 30 /PRNewswire-FirstCa... that it will present at the Piper Jaffray 21st An... 2, 2009 at 1:30 p.m. (ET). Investors may access ....com . In order to register and download any nece..., Covance, with headquarters in Princeton, New J...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, Cardi...e Report ,, http://www.reportlinker.com/p0164...telligence-Report.html ,, Cardiovascular dise... globally. Sudden cardiac arrest survivors are pro...
Breaking Medicine Technology:Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8IDEXX Laboratories to Release 2009 Second Quarter Financial Results 51842 1AMN Healthcare Names New Chief Financial Officer 51839 1AMN Healthcare Names New Chief Financial Officer 51839 2AMN Healthcare Names New Chief Financial Officer 51839 3Vein Removal Method Linked to Bypass Results 51837 1Vein Removal Method Linked to Bypass Results 51837 2Vein Removal Method Linked to Bypass Results 51837 3
...ugment(TM) to be Featured in July...Pa., June 12 Tengion, Inc., a clinical,stage biot...o-organs and,neo-tissues, announced today that the... with its Neo-Bladder Augment(R) will be featured ...180. The paper, "Early Cellular,and Stromal Respon...
...ters of Sleep Maintenance - - Phas...12 Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) an...ospital presented data from Arena,s positive Phase...insomnia in an oral presentation at the SLEEP,2008...l Sleep Societies in,Baltimore, Maryland., APD125...
Other Medicine Technology:Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair 2Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 2Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 3Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 4Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 5Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies 6
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: